Atropine Injection, 2 mg
- Strength
- 2 mg/.7mL
- Form
- Injection
- Class
- Anticholinergic; Cholinergic Muscarinic…
Rafa Laboratories, Ltd.
Not stocked by us — reference only
Listed by Henry Schein, Inc.
| Dosage form | Injection, Solution |
|---|---|
| Route | Intravenous |
| Drug class | Anticholinergic; Cholinergic Muscarinic Antagonist |
| Approval route | ANDA — approved generic |
| NDC code | 0404-9784 |
| FDA application | ANDA215342 |
| RxNorm concept | 1190552 |
| Package sizes listed | 1 |
| Marketed since | June 2025 |
Same active ingredient, different manufacturer, strength or form. Products matching on both ingredient and strength are usually interchangeable — but confirm before switching, especially with modified-release forms.
Rafa Laboratories, Ltd.
Not stocked by us — reference only
Rafa Laboratories, Ltd.
Not stocked by us — reference only
Rafa Laboratories, Ltd.
Not stocked by us — reference only
atropine
Meridian Medical Technologies LLC
Not stocked by us — reference only
atropine
Meridian Medical Technologies LLC
Not stocked by us — reference only
atropine
Meridian Medical Technologies LLC
Not stocked by us — reference only
atropine
Meridian Medical Technologies LLC
Not stocked by us — reference only
atropine
Meridian Medical Technologies LLC
Not stocked by us — reference only
Information only, not medical advice. Nothing on this page indicates that a medication is safe or suitable for you. Speak to a prescriber or pharmacist before starting, stopping or switching any medicine.
Please don't share card details in chat.